Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332118 | 0.86 | CFD (0.31) | CFD | |
| SCHEMBL13093850 | 0.84 | SMN1; SMN2 (0.32) | CFD | |
| SCHEMBL331516 | 0.83 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL332202 | 0.75 | MEN1 (0.33) | — | |
| SCHEMBL13655382 | 0.72 | NPSR1 (0.31) | — | |
| SCHEMBL331823 | 0.70 | — | — | |
| SCHEMBL331527 | 0.70 | ACACB (0.32) | — | |
| SCHEMBL331349 | 0.68 | ALDH1A1 (0.36) | — | |
| SCHEMBL331669 | 0.65 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL8293789 | 0.65 | NPSR1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247539-A1 | Novel Pharmaceuticals | PFIZER INC | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247539-A1 | Novel Pharmaceuticals | ABCB11, PCSK9, SLC10A1 | CFD 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.